Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects

Phase 1CompletedNCT00721474

Wyeth is now a wholly owned subsidiary of Pfizer24 enrolled

Overview

A Study to determine if a high-fat meal has an effect on the pharmacokinetics of bosutinib.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Bosutinib fasting

Bosutinib fed

Sex: ALLMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy men, age 18-50; * Healthy women of nonchildbearing potential, age 18-50. Exclusion Criteria:

Unnamed facility

Tacoma, Washington, United States

Pharmacokinetics (plasma concentrations)

Time frame: 4 weeks

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.